Medivolve Inc (MEDV)

NEO
0.020
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.020/0.025
  • Day's Range:
    0.020 - 0.025
  • Type:Equity
  • Market:Canada
  • ISIN:CA58503M1014
  • CUSIP:58503M101

MEDV Overview

Prev. Close
0.025
Day's Range
0.02-0.025
Revenue
103.52M
Open
0.025
52 wk Range
0.02-0.145
EPS
0.02
Volume
0
Market Cap
7.79M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,632,650
P/E Ratio
1.08
Beta
1
1-Year Change
-69.23%
Shares Outstanding
389,296,008
Next Earnings Date
-
What is your sentiment on Medivolve?
or
Market is currently closed. Voting is open during market hours.

Medivolve Inc News

Medivolve Inc Company Profile

Medivolve Inc Company Profile

Employees
300
Market
Canada

Medivolve, Inc. is a Canada-based healthcare technology company. The Company is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. It offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. It is also engaged in developing technologies to identify, treat, and prevent medical issues. It provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The Company uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • will be 0.5 soon
    3
    • this company needs to update what they're doing more often it's really frustrating when it only happens once every 6 months that is not good management
      0
      • Just noticed in the QSC tweet today that the @medivolve twitter account is up and running now.
        0
        • Just noticed in the QSC tweet today that the @medivolve twitter account is up and running now.
          0
          • Doug mentioned a couple of times they are filling a void in the market with respect to what they can offer. There are only 2 rapid antigen tests approved with EUA that don't require instrumentation. One is the abott which The US gov bought a lot of and the other is the one that QSC has. There was an article this morning in the NY Times stating the need for rapid antigen testing and the lack of availability. QSC is getting in touch with the reporter to let them know of QSC and their plans to roll-out testing across the states. As well, Doug mentioned that they are in discussions with other sports teams on testing to bring back the players but as well in some cases the fans. It's clear they are exploring all avenues.
            0
            •  The Webinar from yesterday now on YouTube. Just type in questcap Dec 10 Webinar and you'll find it. I'm very pleased with the meeting. Interesting information on the break-even point of 5 tests for each cube. 2-3 days to rollout a new cube when they give the go-ahead at a particular location. 100 cubes by the end of the month will be a crucial milestone to meet. If they can do that, more confidence can be gained on their other projections. The math looks really good. It's all about moving forward on all fronts. If you build it, they will come.
              0
              • https://vancouversun.com/sports/hockey/nhl/patrick-johnston-teams-seeking-serology-test-kits-that-might-help-them-return-to-action/wcm/acb3961f-55dc-4157-a074-2a385d3945b8/?utm_source=mj&utm_medium=push&utm_campaign=mj-push_QSC_audience_VS-LP_audience-Full-CA-DE_cmt_CA-DE_M-F_303102&utm_content=QSC-VS-LP
                0
                • any recent info on this stock?
                  0